Clinical Pharmacology Aspects in Patients Treated with TNF Inhibitors During SARS-Cov-2 Pandemic
In this period of global pandemic caused by SARS-Cov-2, it is of paramount importance to recognize all risk factors that may increase the likelihood of infection. In addition to the risk factors known as pre-existing diseases and old age, risk factors could be drug treatments for chronic diseases, s...
Guardado en:
Autores principales: | Francesco Ferrara, Priscilla Santilli, Vilma D'Aiuto, Antonio Vitiello |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Tabriz University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/be82549c30b841528d3e8c6aa0df7dea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Potential role of herbal medicines as a novel approach in sepsis treatment
por: Juveria Usmani, et al.
Publicado: (2021) -
Biological evaluation of novel 6-Arylbenzimidazo [1,2-c] quinazoline derivatives as inhibitors of LPS-induced TNF- alpha secretion
por: GALARCE,GLORIA D, et al.
Publicado: (2008) -
The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis—Real-World Data from Dermatology Practice
por: Georgios Kokolakis, et al.
Publicado: (2021) -
Analysis of the Effect of Proton-Pump Inhibitors on the Course of COVID-19
por: Zhang XY, et al.
Publicado: (2021) -
Comparative effect of immunomodulators on the contents of hydrolase inhibitors and lactoferrin in community-acquired pneumonia in adults
por: M. P. Kostinov, et al.
Publicado: (2020)